GCT President at ECNP – 2018

GCT President, Dr. Jeffrey Apter, joined the annual ECNP Congress in Barcelona, Spain this week. Being Europe’s premier scientific meeting for disease-oriented brain research, conference attracts neuroscientists, psychiatrists, neurologists and psychologists from around the world.

Participants discussed crucial aspects of psychoneurobiology, new advances in the therapy of psychotic disorders,  new findings in applied neuroscience and many other related topics.

GCT has a wide experience in CNS, effectively managing trials in Alzheimer’s disease, Multiple Sclerosis, and Epilepsy in CEE countries, Russia and India. We maintain strong and solid relationships with KOLs and have a huge database of high-recruiting investigative sites.

Please contact us at bd@gctrials.com to learn more!

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.